Drug Trial Radar · NCT06340360
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
94
Actual
Start
Apr 2, 2024
Primary completion
Nov 26, 2025
Study completion Aug 20, 2026
Sponsor
- Lead sponsor
- Nektar TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Apr 1, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an interventional, randomized, double blind, parallel group, placebo-controlled, Phase 2b, 3-arm study to assess the effect of pegylated-recombinant-human interleukin-2 (rezpegaldesleukin) in adult participants with severe to very severe alopecia areata. The estimated duration includes a screening period of up to 35 days, a 36-week treatment period, an optional 16-week treatment extension period, and a 24-week follow-up period. The maximum study duration is approximately 81 weeks for all participants.
Conditions
- Alopecia Areata
Interventions
RezpegaldesleukinDrug
Pharmaceutical form: Injection solution Route of administration: subcutaneous
PlaceboDrug
Pharmaceutical form: Injection solution Route of administration: subcutaneous
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent change from baseline in Severity of Alopecia Tool (SALT) score at Week 36Time frame: Baseline and Week 36
Locations
26 sites in 3 countries. Site status is shown where the registry gives one.
Nektar Investigative Site
Northridge, California
Nektar Investigative Site
Atlanta, Georgia
Nektar Investigative Site
Gurnee, Illinois
Nektar Investigative Site
Indianapolis, Indiana
Nektar Investigative Site
Clinton Township, Michigan
Nektar Investigative Site
Portsmouth, New Hampshire
Nektar Investigative Site
New York, New York
Nektar Investigative Site
Camp Hill, Pennsylvania
Nektar Investigative Site
Frisco, Texas
Nektar Investigative Site
Pflugerville, Texas
Nektar Investigative Site
Surrey, British Columbia, Canada
Nektar Investigative Site
Markham, Ontario, Canada
Nektar Investigative Site
Oakville, Ontario, Canada
Nektar Investigative Site
Richmond Hill, Ontario, Canada
Nektar Investigative Site
Sherbrooke, Quebec, Canada
Nektar Investigative Site
Wroclaw, Lower Silesian Voivodeship, Poland
Nektar Investigative Site
Wroclaw, Lower Silesian Voivodeship, Poland
Nektar Investigative Site
Wroclaw, Lower Silesian Voivodeship, Poland
Nektar Investigative Site
Nowa Sól, Lubusz Voivodeship, Poland
Nektar Investigative Site
Warsaw, Masovian Voivodeship, Poland
Nektar Investigative Site
Warsaw, Masovian Voivodeship, Poland
Nektar Investigative Site
Gdansk, Pomeranian Voivodeship, Poland
Nektar Investigative Site
Katowice, Silesian Voivodeship, Poland
Nektar Investigative Site
Sosnowiec, Silesian Voivodeship, Poland
Nektar Investigative Site
Olsztyn, Warmian-Masurian Voivodeship, Poland
Nektar Investigative Site
Szczecin, West Pomeranian Voivodeship, Poland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.